1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 7, 2001 CALIPER TECHNOLOGIES CORP. (Exact name of registrant as specified in charter) DELAWARE (State or other jurisdiction of incorporation) 0-28229 33-0675808 (Commission File Number) (I.R.S. Employer Identification No.) 605 FAIRCHILD DRIVE MOUNTAIN VIEW, CA 94043-2234 (Address of principal executive offices and zip code) (650) 623-0700 (Registrant's telephone number, including area code) 2 Item 5. Other Events. On January 7, 2001, Caliper announced that it had reached a comprehensive settlement agreement with ACLARA BioSciences on all pending litigation between the two companies. The press release announcing the settlement of the litigation is filed as Exhibit 99.1 and incorporated by reference herein. Item 7. Exhibits. Exhibit 99.1. Press Release Dated January 7, 2001. 3 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CALIPER TECHNOLOGIES CORP. DATE: January 9, 2001 By: /s/ James L. Knighton ------------------------------------- James L. Knighton Vice President, Finance and Chief Financial Officer 4 INDEX TO EXHIBITS Exhibit 99.1. Press Release Dated January 7, 2001.